Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics
FOLD Price/Volume Stats
| Current price | $7.10 | 52-week high | $12.65 |
| Prev. close | $6.91 | 52-week low | $6.20 |
| Day low | $6.99 | Volume | 1,280,345 |
| Day high | $7.25 | Avg. volume | 2,735,885 |
| 50-day MA | $8.42 | Dividend yield | N/A |
| 200-day MA | $9.96 | Market Cap | 2.18B |
FOLD Stock Price Chart Interactive Chart >
Amicus Therapeutics, Inc. (FOLD) Company Bio
Amicus Therapeutics is developing treatments for a broad range of human genetic diseases, with a focus on delivering new benefits to individuals with lysosomal storage disorders. The company was founded in 2002 and is based in Cranbury, New Jersey.
FOLD Price Returns
| 1-mo | -18.30% |
| 3-mo | -26.42% |
| 6-mo | -39.26% |
| 1-year | -33.71% |
| 3-year | -9.32% |
| 5-year | -44.62% |
| YTD | -24.63% |
| 2024 | -33.62% |
| 2023 | 16.22% |
| 2022 | 5.71% |
| 2021 | -49.98% |
| 2020 | 137.06% |
Continue Researching FOLD
Here are a few links from around the web to help you further your research on Amicus Therapeutics Inc's stock as an investment opportunity:Amicus Therapeutics Inc (FOLD) Stock Price | Nasdaq
Amicus Therapeutics Inc (FOLD) Stock Quote, History and News - Yahoo Finance
Amicus Therapeutics Inc (FOLD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...